Efficacy and Safety of Moxonidine in Indian Patients

Solvay

Status and phase: Completed; Phase 3

Conditions: Hypertension

Treatments: Drug: Moxonidine

Study type: Interventional

Funder types: Industry

Identifiers

NCT00160277

S220.3.124

Details and patient eligibility

About

The purpose of this study is to demonstrate efficacy and safety of Moxonidine in Indian subjects.

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

Hypertension

Exclusion criteria

Severe concomitant diseases, CHF, secondary hypertension, severe hypertension, significant hepatic disease, unstable angina

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)